Two German physicists have unveiled a compact magnet layout that outperforms the famed Halbach array, delivering stronger, more even magnetic fields without bulky superconductors.
Their 3D-printed ring stacks matched analytic predictions and could slash the cost of MRI machines while opening doors for levitation tech and particle accelerators.
The National Stem Cell Foundation, which is based in Louisville, has been awarded a $3.1 million grant from NASA to continue research on brain cell behavior in space as a way to find treatments and cures for neurogenerative conditions, and Kentucky is investing $300,000 toward the project as part of a 10% match.
Kentucky’s portion was allocated in the 2024 legislative session in Senate Bill 1. The announcement was made Wednesday, March 26 at the Kentucky State Capitol.
Pointing to the space research Kentucky students have done at the Craft Academy for Excellence in Science and Mathematics and NASA’s presence at Morehead State University, Senate President Robert Stivers, R-Manchester, said it was easy for him and his colleagues to support this type of research in hopes of making Kentucky a hub for it.
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed.
Our brains may work best when teetering on the edge of chaos. A new theory suggests that criticality a sweet spot between order and randomness is the secret to learning, memory, and adaptability. When brains drift from this state, diseases like Alzheimer s can take hold. Detecting and restoring criticality could transform diagnosis and treatment.
*Apply to join Foresight Biotech & Health Extension program:* https://foresight.org/biotech-health-extension-program/ A group of scientists, entrepreneurs, funders, and institutional allies who cooperate to advance biotechnology to reverse aging and extend human healthspan. This group is sponsored by 100 Plus Capital. http://100pluscap.com/
*Foresights Personal Longevity Group* Exploring anti-aging methods, monthly virtual meetings, expert discussions, private group for Foresight Patrons. https://foresight.org/personal-longevity-group/
*Brad Younggren | Therapeutic Plasma Exchange (TPE): A Tool Against Aging and Disease* Bio: Brad Younggren, MD, is CEO and co-founder of Circulate Health, a company dedicated to extending human healthspan. A former U.S. Army physician, Dr. Younggren served as a combat physician in Iraq and was awarded a Bronze Star and Combat Medical Badge. An emergency medicine specialist and seasoned healthcare executive, Younggren has led teams at the cutting edge of medicine for decades. Most recently, he was President and Chief Medical Officer at 98point6, where he led the development and launch of AI-powered primary care solutions. He previously served as CMO at Cue Health, Shift Labs, and Mobisante. At Circulate, Younggren leads an expert team of clinicians and scientists working to harness the potential of therapeutic plasma exchange to advance health and longevity. https://www.circulate.health/
Abstract: Aging is the primary risk factor for most chronic diseases, driving over 90% of U.S. healthcare expenditures. However, emerging science suggests that aging itself can be targeted as a modifiable process. Therapeutic Plasma Exchange (TPE) is a promising intervention that removes harmful substances from the bloodstream, reducing inflammation, disease burden, and potentially reversing aspects of biological aging. Circulate Health is pioneering this space, with clinical trial data demonstrating measurable reductions in biological age and improvements in key biomarkers. Beyond its longevity benefits, recent findings suggest TPE may help reduce microplastics and other environmental toxins—offering a practical, scalable approach to mitigating modern health threats. In this talk, we’ll explore the science behind TPE, its clinical applications, and why Circulate Health’s model makes this groundbreaking treatment accessible to more patients and clinics.
Introducing a new, unifying DNA sequence model that advances regulatory variant-effect prediction and promises to shed new light on genome function — now available via API.
The genome is our cellular instruction manual. It’s the complete set of DNA which guides nearly every part of a living organism, from appearance and function to growth and reproduction. Small variations in a genome’s DNA sequence can alter an organism’s response to its environment or its susceptibility to disease. But deciphering how the genome’s instructions are read at the molecular level — and what happens when a small DNA variation occurs — is still one of biology’s greatest mysteries.
Today, we introduce AlphaGenome, a new artificial intelligence (AI) tool that more comprehensively and accurately predicts how single variants or mutations in human DNA sequences impact a wide range of biological processes regulating genes. This was enabled, among other factors, by technical advances allowing the model to process long DNA sequences and output high-resolution predictions.
Scientists have developed a device intended to detect disease markers in human breath, which could someday offer a potential alternative to blood, urine or saliva tests.
In a new study, researchers demonstrate long-term, non-invasive monitoring of blood sodium levels using a system that combines optoacoustic detection with terahertz spectroscopy. The paper is published in the journal Optica.
Accurate measurement of blood sodium is essential for diagnosing and managing conditions such as dehydration, kidney disease and certain neurological and endocrine disorders.
Terahertz radiation, which falls between microwaves and the mid-infrared region of the electromagnetic spectrum, is ideal for biological applications because it is low-energy and non-harmful to tissues, scatters less than near-infrared and visible light and is sensitive to structural and functional biological changes.